key: cord-0258566-qxjzmlkx
authors: Caple, A.; Dimaano, A.; Sagolili, M. M.; Uy, A. A.; Aguirre, P. M.; Alano, D. L.; Camaya, G. S.; Ciriaco, B. J.; Clavo, P. J.; Cuyugan, D.; Fermo, C. F. G.; Lanete, P. J.; La Torre, A. J.; Loteyro, T. A.; Lua, R. M.; Manansala, N. G.; Mosquito, R. W.; Octaviano, A. M.; Orfanel, A. E.; Pascual, G. M.; Sale, A. J.; Tendenilla, S. L.; Trinidad, M. S.; Trinidad, N. J.; Verano, D. L.; Austriaco, N.
title: Interrogating COVID-19 Vaccine Hesitancy in the Philippines with a Nationwide Open-Access Online Survey
date: 2021-09-15
journal: nan
DOI: 10.1101/2021.09.11.21263428
sha: 7e859341cfd19bd9516606221c254285eb3c2aea
doc_id: 258566
cord_uid: qxjzmlkx

To mitigate the unprecedented health, social, and economic damage of COVID-19, the Philippines is undertaking a nationwide vaccination program to mitigate the effects of the global pandemic. In this study, we interrogated COVID-19 vaccine hesitancy in the country by deploying a nationwide open-access online survey, two months before the rollout of the national vaccination program. The Health Belief Model (HBM) posits that people are likely to adopt disease prevention behaviors and to accept medical interventions like vaccines if there is sufficient motivation and cues to action. A majority of our 7,193 respondents (62.5%) indicated that they were willing to be vaccinated against COVID-19. Moreover, multivariable analysis revealed that HBM constructs were associated with vaccination intention in the Philippines. Perceptions of high susceptibility, high severity, and significant benefits were all good predictors for vaccination intent. We also found that external cues to action were important. Large majorities of our respondents would only receive the COVID-19 vaccines after many others had received it (72.8%) or after politicians had received it (68.2%). Finally, our study revealed that most (21%) were willing to pay an amount of PHP1,000 [USD20] for the COVID-19 vaccines with an average willing-to-pay amount of PHP1,892 [USD38].

On January 30, 2020, the Department of Health (DOH) of the Philippines reported its first case of COVID-19, a novel respiratory disease first identified in Wuhan, China, that is caused by the coronavirus, SARS-CoV-2 (Xie et al., 2020; Zhu et al., 2020; Guan et al., 2020) . With widespread human-to-human transmission, the virus is highly contagious, and the COVID-19 pandemic is now of global concern (Burki, 2020; Paules, Marston & Fauci, 2020; Case et al., 2021; Novelli et al., 2021) . As of August 25, 2021, there have been 1,883,088 confirmed cases and 32,492 deaths from COVID-19 reported by the DOH throughout the archipelago (ncovtracker.doh.gov.ph).

Vaccination has long been regarded as the most effective means for combating infectious disease (Rappuoli et al., 2014; Sathyanarayana et al., 2020) . The Philippines began its national vaccine drive against COVID-19 on March 1, 2021, with the goal of vaccinating seventy million of its citizens by the end of the calendar year (Inter-Agency Task Force for the Management of Emerging Infectious Disease, 2021). One of the ongoing challenges for this campaign is the vaccine hesitancy among the Filipino people (Alfonso et al., 2021) .

The Health Belief Model (HBM) posits that people are likely to adopt disease prevention behaviors and to accept medical interventions like vaccines if there is sufficient motivation and cues to action (Rosenstock, Strecher & Becker, 1988) . Motivational factors include perceived susceptibility to and severity of the disease and perceived benefits of the vaccine. Cues to action include information, people, and events that nudge the individual towards vaccination. The HBM has been adopted as a conceptual framework that has been used to evaluate the beliefs and attitudes toward a diversity of vaccines including the influenza, human papillomavirus, and hepatitis B vaccines (Teitler-Regev, Shahrabani & Benzion, 2011; Donadiki et al., 2014; Hu et al., 2017; Chen et al., 2019) . Moreover, several studies have shown that the HBM constructs can serve as an important predictor of influenza vaccination uptake (Brewer et al., 2007; Shahrabani, Benzion & Yom Din, 2009; Shahrabani & Benzion, 2010; Tsutsui, Benzion & Shahrabani, 2012) . During the COVID-19 pandemic, the HBM was used to assess the root causes of COVID-19 vaccine hesitancy in the Asia-Pacific region and beyond (Wong et al., 2020 (Wong et al., , 2021 Lin et al., 2020; Yu et al., 2021; Kabir et al., 2021; Shmueli, 2021; Huynh et al., 2021; Tao, Wang & Liu, 2021; Mahmud et al., 2021; Banik et al., 2021) .

In this study, we interrogated COVID-19 vaccine hesitancy in the Philippines by deploying a nationwide open-access online survey, two months before the rollout of the national vaccination program. Based on the HBM framework, we hypothesized that acceptance of a COVID-19 vaccine depends upon beliefs about susceptibility to and severity of , and beliefs about the perceived benefits of the vaccine. We also wanted to assess possible cues to vaccination for our Filipino respondents.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 A majority of our 7,193 respondents (62.5%) indicated that they were willing to be vaccinated against COVID-19. Moreover, multivariable analysis revealed that HBM constructs were associated with vaccination intention in the Philippines. Perceptions of high susceptibility, high severity, and significant benefits were all good predictors for vaccination intent. We also found that external cues to action were important. Large majorities of our respondents would only receive the COVID-19 vaccines after many others had received it (72.8%) or after politicians had received it (68.2%). Finally, our study revealed that most (21%) were willing to pay an amount of PHP1,000 [USD20] for the COVID-19 vaccines with an average willing-to-pay amount of PHP1,892 [USD38] . Based on these findings, we inaugurated the UST-CoVAX public awareness campaign that seeks to increase vaccine confidence in the Philippines by addressing the specific fears and concerns of our Filipino respondents and by sharing the personal vaccination testimonies of Filipinos around the world.

The current study design was a cross-sectional, anonymous, web-based survey-developed using Qualtrics--conducted from January 15, 2021 to January 29, 2021. Our research team deployed an anonymous link via the social platforms of the University of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Santo Tomas (UST) like Twitter and Facebook and university mailing lists including the UST School of Science and UST Student Council to distribute the survey. Participants were encouraged to distribute the survey link to their contacts throughout the country.

The questionnaire was written in both Filipino and English. Responses used for data collection were limited to respondents who were at least 18 years old.

The survey consisted of questions and statements that assessed the following: 1) demographics, health status, and COVID-19 experience, 2) intent to receive a COVID-19 vaccine; 3) perceived susceptibility to and severity of COVID-19; 4) perceived benefits of a COVID-19 vaccine; 5) willingness to pay (WTP) for a COVID-19 vaccine; and 6) confidence in COVID-19 vaccines made in other countries.

Demographics, health status, and COVID-19 experience: Demographic information including age, gender, marital status, education, occupation, monthly income, and urban or rural location of residence were collected. Participants were also asked if they have an existing chronic condition, if they ever tested positive for COVID-19, and to indicate if they know someone who has tested positive for COVID-19.

Intent to receive a COVID-19 vaccine: Intention to receive a COVID-19 vaccine was assessed using a one-item question ("If a vaccine for COVID-19 is available in the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Philippines, would you use it?") on a five-point scale ranging from 1 = 'definitely no' to 5 = 'definitely yes'. Responses were additionally recoded into two distinct categories: vaccine hesitant (responses included: 'definitely no ', 'probably no', and 'unsure') and not vaccine hesitant (responses included: 'probably yes' and 'definitely yes').

Perceived susceptibility to and severity of COVID-19: HBM-derived items were used to assess individual beliefs about a COVID-19 vaccine. Questions posed to participants assessed perceived susceptibility of COVID-19 (two items), perceived severity of COVID-19 (three items), and cues to action (two items). All response items were on a four-point scale ranging from 'strongly agree' to 'strongly disagree'. For analysis purposes, all responses were coded as either 'agree' (responses included: 'strongly agree ' and 'agree') or 'disagree' (responses included: 'strongly disagree' and 'disagree').

Perceived benefits of a COVID-19 vaccine: Perceived benefits were queried using two items. All response items were rated on a four-point scale ranging from 'strongly agree' to 'strongly disagree'. Similar to perceived susceptibility to and severity of COVID-19, all responses were coded as either 'agree' or 'disagree'. In addition to perceived benefits of a COVID-19 vaccine, respondents were also asked to rate-on a four-point scale ranging from 'strongly agree' to 'strongly disagree'-perceived barriers surrounding a COVID-19 vaccine (e.g., 'I worry about the possible side-effects of the COVID-19 vaccine.'; 'I worry . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 about fake COVID-19 vaccines.'). For analysis purposes, all responses were coded as either 'agree' or 'disagree'.

Willingness to pay for COVID-19 vaccine: Willingness to pay (WTP) was measured using a one-item question ("What is the maximum amount you are willing to pay for two doses of the COVID-19 vaccine?") on an eight-point scale ('PHP500', 'PHP1, 000', 'PHP1, 500', 'PHP2, 000', 'PHP2, 500', 'PHP3, 000', 'PHP3, 500', and 'PHP4, 000') . The price range options were based on the approximate minimum-maximum price range of current vaccines in the Philippines.

Confidence in an international COVID-19 vaccine: Participants were asked to rate their level of confidence in using a vaccine for COVID-19 made in China, Russia, and the USA or Europe on a four-point scale ('completely not confident', 'not confident', 'confident', and 'completely confident'). Preference for the nationality of a manufacturer of the COVID-19 vaccine was also inquired.

Our study protocol (Protocol Number 21-026) was reviewed and approved by the Institutional Review Board of Providence College on January 15, 2021. An informed consent statement was included in the survey instrument to welcome respondents who had clicked on the anonymous survey link provided by Qualtrics.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint

All statistical analyses were conducted using Statistical Package for the Social Sciences (SPSS) version 27. A p-value of less than .05 was considered statistically significant. Frequency tables, charts, and proportions were used for data summarizationproportions and their respective 95% confidence intervals (CI) were calculated for each predictor variable. The model fit of binary logistic regression analysis was calculated using the Hosmer-Lemeshow goodness-of-fit test (Hosmer, Lemeshow & Sturdivant, 2013) .

Participant responses to the one-item intent to receive COVID-19 vaccine ('If a vaccine for COVID-19 is available in the Philippines, would you use it?') was coded into two categories: vaccine hesitant (responses included: 'definitely no ', 'probably no', 'unsure') and not vaccine hesitant (responses included: 'probably yes', 'definitely yes'). The eight options of WTP for a COVID-19 vaccine were categorized into three categories (PHP500-1,000, PHP1,500-2,500, PHP3,000-4,000). A multinomial logistic regression was employed to model factors associated with WTP for a COVID-19 vaccine with the lowest (PHP500-1,000) as the reference. We ran univariate analyses followed by a binary logistic regression analysis, including all factors showing significance (p < .05), to determine which factors predicted individual intention to receive a COVID-19 vaccine. Only significant factors in the univariate analyses were included in the binary logistic regression analysis.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint

A total of 7,193 complete survey responses were received. Responses received represented participants with diverse demographics as shown in Table 1 , and from all of the regions of the Philippines (Figure 1 ). The study sample had a higher representation of younger adults aged 18 to 30 years old (52.4%), which is not unexpected given that our open access survey was deployed on social media. Additionally, the majority of participants identified as female (66.6%), single (65.7%), had obtained a college/university degree or above (84%), and lived in an urban location (78.9%). Only a small portion of the sample reported having an existing chronic condition (16.4%) while 17.5% reported having either 'very poor', 'poor', or 'fair' health. Additionally, 72.8% of the sample reported knowing someone who had tested positive for COVID-19.

As displayed in Figure 2 , with regards to perceived susceptibility to COVID-19 vaccines, the minority of participants reported that they thought that there was a high chance of personally contracting COVID-19 in the next few months (31.5%). However, when prompted to report worry about the likelihood of getting COVID-19, the majority of participants reported that they were worried (84.1%) and that COVID-19 is a serious . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 illness with life-threatening conditions (96.3%). Furthermore, a significant majority (93.1%) reported that they were afraid of getting COVID-19, and that they would get very sick if they were infected with the virus (75%). The respondents in the survey reported significant perceived benefits for the COVID-19 vaccines. A large portion of participants noted that they believed that a COVID-19 vaccine would decrease the chances of getting COVID-19 (88.1%) and that the vaccine would alleviate their anxieties about catching the virus (84.5%). Notably, significant majorities of our respondents reported that they had worries about possible side-effects (89.6%), effectiveness (87.1%), safety (88.8%), and high cost (78%) of the vaccines. Nearly all were concerned about the possibility of fake jabs (97.4%). Many participants noted they would only receive the COVID-19 vaccines after many others had received it (72.8%) or after politicians had received it (68.2%). Figure 3 shows the proportion of responses for intention to take a COVID-19 vaccine if one were available in the Philippines. A total of 4,497 of the participants (62.5%) responded either 'probably yes' or 'definitely yes' to COVID-19 vaccine intentdemonstrating that they were not vaccine hesitant-while 2,696 (37.4%) displayed vaccine hesitancy (responses included 'definitely no', 'probably no', and 'unsure'). More . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint specifically, the majority of responses were 'probably yes' (32.8%, n = 2,358), followed by 'definitely yes' (29.7%, n = 2,139), 'unsure' (28%, n = 2,017), 'probably no' (6.4%, n = 461), and 'definitely no' (3%, n = 318). Demographics of respondents who intend (not vaccine hesitant) and do not intend (vaccine hesitant) to take a COVID-19 vaccine is displayed in Table 1 . Table 2 shows the univariate and binary analyses of factors associated with a vaccine hesitant and a not vaccine hesitant intention by demographics and health belief constructs. Univariate analyses showed a significantly higher proportion of participants who were single (63.6%) expressed an intention to take a COVID-19 vaccine (not vaccine hesitant) than married participants (60.4%). However, the association was not significant in the binary analysis. By occupational category, a significantly higher proportion of respondents that were not vaccine hesitant included those who identified as students (65.5%) and professional/white collar workers (62%). Significant differences were noted in vaccine hesitancy for COVID-19 by location, whereby individuals in an urban location (65%) reported a higher proportion of an intention to vaccinate compared to respondents in rural locations (53.1%).

By demographics, binary analyses revealed that males have greater odds of an intention to take a COVID-19 vaccine (OR = 1.222, 95% CI [1.078-1.386]) than females.

Being self-employed (OR = .776, 95% CI [.586-1.026]), a student (OR = 1.352, 95% CI . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Most of the constructs of the HBM were significantly associated with an intention to take a COVID-19 vaccination in the univariate analyses. While 72.8% of participants reported they would only take the COVID-19 vaccine after many others receive it ( Figure   3 ), disagreement with that notion (OR = 1.894, 95% CI [1.597-2.247]) was the strongest predictor for an intent to vaccinate. Intent to receive a COVID-19 vaccine only once politicians receive it (OR = 1.411, 95% CI [1.214-1.640]) was also a strong predictor of intention to take a COVID-19 vaccine.

Willingness to Pay (WTP) Table 4 shows the results of the univariate and multinomial regression analyses for the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10. 1101 Vaccine Brand Preference Figure 4 shows confidence in foreign-made (i.e., China, Russia, and the USA or Europe) COVID-19 vaccines. The vast majority of participants were 'confident ' (59.7%) or 'completely confident' (23.1%) in a COVID-19 vaccine made in the USA or Europe. In contrast, a majority of participants indicated they were either 'completely not confident' (38.2%, 16.5%) or 'not confident' (46.8%, 49.2%) in a vaccine developed in China and Russia respectively. Findings on the preference of where a COVID-19 vaccine is made revealed respondents reported a preference for a vaccine made in the USA or Europe (53.4%) while 44.6% of participants indicated no preference of where a COVID-19 vaccine is made as long as it is safe and effective.

In this study, we sought to interrogate the extent of COVID-19 vaccine hesitancy in the Philippines and to determine whether the Health Belief Model (HBM) could be used to explain this hesitancy among Filipinos. We deployed our nationwide open-access online survey for a two week period (January 15-29, 2021), a month before the first COVID-19 vaccines were administered in the archipelago on March 1, 2021.

We received nearly 7,200 completed surveys from around the country. The majority of responses (5,348; 74%) were from the three geographical and administrative regions, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint National Capital Region (NCR), Region III, and Region IVA, that encompass and surround the capital city of Manila. Together, these three regions, which have 38% of the population, have weathered the worst of the COVID-19 pandemic in the Philippines with about 60% of the total nationwide reported cases (ncovtracker.doh.gov.ph).

A majority of our respondents (62.5%) indicated that they were willing to be vaccinated by responding either 'probably yes' or 'definitely yes' to COVID-19 vaccine intent. As a point of comparison, a survey conducted by Pulse Asia from February 22, 2021, to March 3, 2021, which was a month after our survey period, reported that only 16% of the 2,400 Filipinos they interviewed face-to-face indicated that they would have themselves vaccinated, while 23% said that they "cannot say" if they would have themselves vaccinated (Pulse Asia, 2021).

There are many possible reasons for this difference in reported vaccine confidence but three immediately come to mind. First, our survey was an open access online survey while the Pulse Asia survey involved face-to-face interviews of Filipinos throughout the country. By their very nature, online surveys are not representative of the population at large because access to the internet is uneven, especially in developing countries. Second, the respondents of our survey were skewed in favor of individuals living in those urban centers around the capital that have endured the most stringent quarantine restrictions of the pandemic. It is likely that this pandemic experience would have heightened their . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint desire to be vaccinated as compared to those Filipinos who live in the countryside where viral transmission was sporadic and pandemic restrictions were relatively innocuous.

Notably, our bivariate analysis confirms that individuals in an urban location (65%) reported a higher proportion of an intention to vaccinate compared to respondents in rural locations (53.1%). Finally, the intervening month between the two surveys witnessed Multivariable analysis revealed that HBM constructs were associated with vaccination intention in the Philippines, which is in accordance with other studies from the Asia-Pacific region (Wong et al., 2020 (Wong et al., , 2021 Lin et al., 2020; Yu et al., 2021; Kabir et al., 2021; Huynh et al., 2021; Tao, Wang & Liu, 2021) Perceptions of high susceptibility, high severity, and significant benefits were all good predictors for vaccination intent. A study to interrogate vaccine hesitancy among Filipinos in two urban communities in Manila before the COVID-19 pandemic also found that respondents who believed in the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint protective nature of vaccines were less likely to report vaccine hesitancy and were nine times less likely to refuse vaccination for their children because of negative media exposure (Migriño et al., 2020) .

Perceived barriers against COVID-19 immunization reported by our respondents including worries about the side-effects, effectiveness, and safety of the vaccines have also been reported by these other HBM studies. These are triggers for hesitancy that can be eradicated with scientific explanation. Public health authorities in the Philippines should address these issues. In response to the findings of this survey, we have initiated a public awareness campaign in the Philippines to directly respond to these concerns by generating infographics and other publication materials to alleviate these worries (https://www.facebook.com/USTCoVAX/).

Interestingly, we discovered that our Filipino respondents were overwhelmingly worried about fake COVID-19 vaccines (97.4%). Similar concerns have been raised in India (Choudhary et al., 2021) though this was not observed in China (Lin et al., 2020) .

This suggests that the national governments of developing countries should ensure the integrity of the vaccine rollout to reassure their citizens that they are not receiving "dud" doses.

Next, we found that external cues to action were important. Large majorities of our respondents would only receive the COVID-19 vaccines after many others had received . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint it (72.8%) or after politicians had received it (68.2%). We observed that disagreement with the statement that the individual would receive the COVID-19 vaccine only after many others had received it was the strongest predictor for an intent to vaccinate among our Filipino respondents. This segment of the population could represent citizens who so want to be vaccinated that they are willing to put aside the collectivist mindset that is strongly rooted in Filipino culture (Grimm et al., 1999) . However, given the high numbers of respondents who indicated that they were waiting for others to first receive the vaccine, our UST-CoVAX public awareness program began sharing the personal vaccination testimonies of Filipinos around the world on social media platforms to show Filipinos in the Philippines that others like them had already received the COVID-19 vaccines (https://www.facebook.com/USTCoVAX/).

Our study revealed that most (21%) were willing to pay an amount of PHP1,000

[USD20] for the COVID-19 vaccines with an average willing-to-pay amount of PHP1,892

[USD38]. Multinomial logistic regression showed that individuals aged 31 to 40, single respondents, and students had the highest WTP in their demographic categories respectively. Since the minimum daily wage in the Philippines in 2021 is PHP537 [USD10.54], the average WTP amount of PHP1,892 [USD38] remains a significant investment in the health of the individual, equivalent to nearly four days of wages. This . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint suggests that the COVID-19 vaccines should be provided free of charge to ensure population-wide access among all Filipinos across the economic classes.

Finally, our analysis revealed significant vaccine brand preference among our Filipino respondents. The vast majority of participants were 'confident' (59.7%) or 'completely confident' (23.1%) in a COVID-19 vaccine made in the USA or Europe. In contrast, a majority of participants indicated they were either 'completely not confident' (38.2%, 16.5%) or 'not confident' (46.8%, 49.2%) in a vaccine developed in China and Russia respectively. These findings mirror those reported by the Pulse Asia survey already described above that showed that a majority (52%) of Filipinos who were opting to get vaccinated preferred the Pfizer vaccine (Pulse Asia, 2021). This vaccine preference has to be managed by the national government to prevent Filipinos from unnecessarily delaying immunization to obtain their preferred vaccine brand.

Our study has several limitations. As we already noted above, the use of an openaccess online survey may result in sampling bias so we cannot generalize our findings to the entire Filipino population (Wyatt, 2000; Eysenbach & Wyatt, 2002) . It is notable that young people aged 18-30 years, who make up around 28% of the population of the Philippines (https://www.populationpyramid.net/philippines/), constitute 52.4% of our respondents. Unexpectedly, however, senior citizens aged 61-89 years of age, who constitute 8% of the country's population are also over-represented with 11.8% of the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint respondents. Furthermore, the responses were based on self-report and may be subject to self-reporting bias and a tendency to report socially desirable responses especially in a strongly collectivist society like the Philippines. One final limitation of our study is the bias associated with the assessment of acceptance and WTP for a hypothetical COVID-19 vaccine before any concrete vaccines actually exist (Schmidt & Bijmolt, 2019). We therefore intend to undertake a follow-up survey once the vaccine rollout in the country has stabilized. Nonetheless, despite these shortcomings, we believe that our findings will provide insights to support the vaccine rollout of the COVID-19 vaccines in the Philippines by helping public health authorities to understand vaccine demand and vaccine hesitancy in the country. Indeed, based on these findings, we inaugurated the UST-CoVAX public awareness campaign that seeks to increase vaccine confidence in the Philippines by addressing the specific fears and concerns of our Filipino respondents and by sharing the personal vaccination testimonies of Filipinos around the world.

(https://www.facebook.com/USTCoVAX/). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Guan WJ., Ni ZY., Hu Y., Liang WH., Ou CQ., He JX., Liu L., Shan H., Lei CL., Hui DSC., Du B., Li LJ., Zeng G., Yuen KY., Chen RC., Tang CL., Wang T., Chen PY., Xiang J., Li SY., Wang JL., Liang ZJ., Peng YX., Wei L., Liu Y., Hu YH., Peng P., Wang JM., Liu JY., Chen Z., Li G., Zheng ZJ., Qiu SQ., Luo J., Ye CJ., . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; Know anyone who has tested positive for COVID-19

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint Hosmer-Lemeshow test, chi-square: 13.316, p = .101; Nagelkerke R 2 = .384.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101/2021.09.11.21263428 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted September 15, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 

From Dengvaxia to Sinovac: Vaccine Hesitancy in the Philippines

Understanding the determinants of COVID-19 vaccination intention and willingness to pay: findings from a population-based survey in Bangladesh

Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination

Outbreak of coronavirus disease 2019

On the road to ending the COVID-19 pandemic: Are we there yet?

Determinants of nurses' willingness to receive vaccines: Application of the health belief model

Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China

Al-Mohaimeed A. 2021. The health belief model predicts intention to receive the covid-19 vaccine in saudi arabia: Results from a cross-sectional survey. Vaccines 9

Factors affecting vaccine hesitancy among families with children 2 years old and younger in two urban communities in Manila

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy

Coronavirus infections-more than just the common cold

Goodness-of-Fit test